{
  "zip": "M5X 1C9",
  "sector": "Healthcare",
  "longBusinessSummary": "Cybin Inc., a life sciences company, focuses on the psychedelic drug development to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.",
  "city": "Toronto",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.cybin.com",
  "maxAge": 1,
  "address1": "100 King Street West",
  "industry": "Biotechnology",
  "address2": "Suite 5600",
  "previousClose": 1.4668,
  "regularMarketOpen": 1.72,
  "twoHundredDayAverage": 1.462625,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 1.72,
  "navPrice": null,
  "averageDailyVolume10Day": 149375,
  "totalAssets": null,
  "regularMarketPreviousClose": 1.4668,
  "fiftyDayAverage": 1.462625,
  "trailingAnnualDividendRate": null,
  "open": 1.72,
  "averageVolume10days": 149375,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 1.3722,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 167032,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 183426496,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 149375,
  "priceToSalesTrailing12Months": null,
  "dayLow": 1.3722,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 167032,
  "fiftyTwoWeekHigh": 1.72,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.2,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 1.72,
  "exchange": "PNK",
  "shortName": "CYBIN INC",
  "longName": "Cybin Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CLXPF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_666815486",
  "uuid": "d4df134f-9c6b-3304-a549-0355df2c2960",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 131279000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.068,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1585612800,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -1943647,
  "trailingEps": -0.259,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 21.399998,
  "heldPercentInsiders": 2.5268,
  "nextFiscalYearEnd": 1648684800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 37610130,
  "enterpriseValue": 97561984,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1604966400,
  "lastSplitFactor": "1:6",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 1.72,
  "logo_url": "https://logo.clearbit.com/cybin.com"
}